Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT

This study is testing a new drug to understand how the body processes it (absorption, breakdown, and elimination), with a focus on how it behaves in patients with a specific type of cancer, helping researchers determine the right dose and schedule for future treatments. **You may be eligible if...** - You have a cancer diagnosis that meets the study criteria - Your liver and kidneys are functioning well enough to process the study drug - You are in adequate overall health (measured by a performance score) - You have not received certain treatments that could interfere with the study **You may NOT be eligible if...** - You have serious liver or kidney problems - You are taking medications that could interact with the study drug - You are pregnant or breastfeeding - You have had recent major surgery - You have a serious infection or uncontrolled medical condition Talk to your doctor to see if this trial is right for you.